Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Leukemia Research|January 9, 2007
Gene expression analysis identifies a genetic signature potentially associated with response to alpha-IFN in chronic phase CML patientsAnette Hagberg, Ulla Olsson-Strömberg, Ulrika Wickenberg-Bolin, et al.
Leukemia Research|October 7, 2016
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuliStina Söderlund, Lisa Christiansson, Inger Persson, et al.
Blood|August 10, 2017
KIT signaling is dispensable for human mast cell progenitor developmentJoakim S Dahlin, Maria Ekoff, Jennine Grootens, et al.
Leukemia Research|February 15, 2020
Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapyStina Söderlund, Inger Persson, Mette Ilander, et al.
Lipids in Health and Disease|July 7, 2023
Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patientsAina Vaivade, Anna Wiberg, Payam Emami Khoonsari, et al.
Molecular Cancer Therapeutics|March 13, 2015
The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responsesLisa Christiansson, Stina Söderlund, Sara Mangsbo, et al.
Bone Marrow Transplantation|April 10, 2019
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registryAnna Lübking, Arta Dreimane, Fredrik Sandin, et al.
Annals of Internal Medicine|June 14, 2016
Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort StudyTorsten Dahlén, Gustaf Edgren, Mats Lambe, et al.
European Journal of Haematology|July 19, 2016
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML registerStina Söderlund, Torsten Dahlén, Fredrik Sandin, et al.
British Journal of Haematology|March 31, 2015
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor eraNiklas Gunnarsson, Leif Stenke, Martin Höglund, et al.
Pageof 5